Saving Medicare through Patient-Centered Changes — The Case of Injectables
Medicare covers the cost of injectable drugs only when they're administered in a hospital or physician's office, but considerations of convenience, cost, and quality all argue for encouraging patients to participate in their own care by allowing self-administration. As we debate Medicare...
Saved in:
Published in | The New England journal of medicine Vol. 368; no. 17; pp. 1572 - 1573 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Waltham, MA
Massachusetts Medical Society
25.04.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Medicare covers the cost of injectable drugs only when they're administered in a hospital or physician's office, but considerations of convenience, cost, and quality all argue for encouraging patients to participate in their own care by allowing self-administration.
As we debate Medicare's solvency and the ever-rising cost of health care and health insurance, it makes sense to examine easily implementable policies that will reduce costs. Total Medicare expenditures were $549 billion in 2011.
1
Pursuing more prudent (though perhaps less than ideal) policies, such as those in place in Canada, might have saved over $2 trillion between 1980 and 2009.
2
Ideally, we would find ways to reduce costs without harming beneficiaries, so the $716 billion “cut” to Medicare under the Affordable Care Act (ACA) actually represents savings to be achieved over a 10-year period from anticipated reductions in payments . . . |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJMp1213485 |